Divi's Laboratories informs about outcome of board meeting

06 Nov 2023 Evaluate
Divi's Laboratories has informed that the Board of Directors of the Company at its meeting held on November 06, 2023 has, approved the Unaudited Financial Results for the quarter and half year ended September 30, 2023. In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, it enclose the following: Unaudited standalone financial results for the quarter and half year ended September 30, 2023 along with Limited Review Report of the Statutory Auditors thereon; Unaudited consolidated financial results for quarter and half year ended September 30, 2023 along with Limited Review Report of the Statutory Auditors thereon; Press Release on the said Financial Results of the Company. The Board meeting commenced at 10.45 Hrs and concluded at 12.20 Hrs.

The above information is a part of company’s filings submitted to BSE.

Divis Lab Share Price

5908.00 11.10 (0.19%)
08-Jan-2025 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1869.75
Dr. Reddys Lab 1370.90
Cipla 1498.60
Lupin 2352.55
Zydus Lifesciences 1010.00
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.